These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 4884296)
1. Clinical evaluation of amiloride, a potassium-sparing diuretic. Lant AF; Smith AJ; Wilson GM Clin Pharmacol Ther; 1969; 10(1):50-63. PubMed ID: 4884296 [No Abstract] [Full Text] [Related]
2. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites. Yamada S; Reynolds TB Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268 [No Abstract] [Full Text] [Related]
3. [Course of diuresis in heart failure during ethacrynic acid and amiloride therapy]. Heinz N Munch Med Wochenschr; 1971 Dec; 113(49):1660-3. PubMed ID: 5171488 [No Abstract] [Full Text] [Related]
4. Combinations of diuretics in the treatment of edema. Leiter L Am Heart J; 1970 Sep; 80(3):422-6. PubMed ID: 4915356 [No Abstract] [Full Text] [Related]
5. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism. Radó JP; Marosi J; Takó J Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990 [No Abstract] [Full Text] [Related]
6. [Diuretics in cirrhosis. Accidents. Indications]. Andrieu J; Lesueur G Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378 [No Abstract] [Full Text] [Related]
7. Usefulness of amiloride hydrochloride (MK-870) as an adjuvant in long-term treatment of hepatic cirrhosis. Sethy VH; Mehta JM; Sheth UK J Clin Pharmacol New Drugs; 1971; 11(2):146-51. PubMed ID: 5206472 [No Abstract] [Full Text] [Related]
8. Extrarenal effects of diuretic agents. Riecker G Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):106-10. PubMed ID: 4924317 [No Abstract] [Full Text] [Related]
9. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts]. Vesin P Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553 [No Abstract] [Full Text] [Related]
13. Evaluation of MK-870: a new potassium-sparing diuretic. Singh BN; Richmond DE; Wilson JD; Simmonds HA; North JD Br Med J; 1967 Jan; 1(5533):143-6. PubMed ID: 6015647 [No Abstract] [Full Text] [Related]
14. Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870). McNay JL; Oran E Metabolism; 1970 Jan; 19(1):58-70. PubMed ID: 5410663 [No Abstract] [Full Text] [Related]
15. Diuretics. Harrington JT Am J Hosp Pharm; 1975 Mar; 32(3):316-9. PubMed ID: 1136980 [TBL] [Abstract][Full Text] [Related]
16. Ethacrynic acid: assessment of saluretic and diuretic potency in patients with severe chronic renal failure. Edwards KD; Sinnett PF; Stewart JH Med J Aust; 1967 Feb; 1(8):375-81. PubMed ID: 6021236 [No Abstract] [Full Text] [Related]
17. What's new in diuretic therapy. Greenberg A Am Fam Physician; 1986 May; 33(5):200-12. PubMed ID: 3706097 [No Abstract] [Full Text] [Related]
18. Acute effects of a new potassium-sparing diuretic, amiloride hidrochloride (MK-870), alone and in combination with acetazolamide in normal human subjects. Mattar E; Cruz HM; Cruz J AMB Rev Assoc Med Bras; 1969 Sep; 15(9):369-76. PubMed ID: 4909931 [No Abstract] [Full Text] [Related]